CSPC Pharmaceutical Group Limited
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
8/10
|
12.67 | 31.48 | -59.75% | 393.9 | -96.78% |
| P/S |
|
2.37 | 3.24 | -26.95% |
|
|
| P/BV |
|
2.13 | 3.36 | -36.75% |
|
|
| P/FCF |
|
3.76 | 21.26 | -82.32% |
|
|
| Ev/Ebitda |
|
7.43 | 9.95 | -25.41% |
|
|
| Ev/S |
|
2.01 | 1.89 | 6.03% |
|
|
| Ev/FCF |
|
27.61 | 19.96 | 38.35% |
|
|
| E/P |
|
0.6837 | 1.47 | -53.44% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
8/10
|
27.03 | 24.35 | 11.01% | 25.61 | +5.51% |
| ROE |
|
17.69 | 13.19 | 34.1% |
|
|
| ROA |
|
12.69 | 6.14 | 106.77% |
|
|
| ROIC |
|
23.03 | 15.56 | 48.02% |
|
|
| ROS |
|
18.68 | 12.56 | 48.73% |
|
|
| ROCE |
|
21.08 | 14.36 | 46.84% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
0.0832 | 6.21 | -98.66% | 0.0674 | +23.4% |
| Nеt Debt/Ebitda |
|
-1.33 | -5.72 | -76.76% |
|
|
| Debt/Ratio |
|
0.0153 | 0.2122 | -92.8% |
|
|
| Debt/Equity |
|
0.211 | 12.49 | -98.31% |
|
|
| Debt/Net Income |
|
0.1204 | 15.05 | -99.2% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
10/10
|
5.67 | 1.76 | 221.89% | 2.85 | +98.85% |
| Number of years of dividend growth |
|
5 | 1.21 | 312.79% | ||
| DSI |
|
1 | 0.7783 | 28.48% |
|
|
| Average dividend growth |
|
20.47 | -269.81 | -107.59% |
|
|
| Average percentage for 5 years |
|
2.85 | 2.8 | 1.7% |
|
|
| Average percentage for payments |
|
32.15 | 246.79 | -86.97% |
|
|
| Difference from average difference in sector |
|
3.91 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
7/10
|
56.54 | 140.59 | -59.78% | ||
| Growth impulse Ebitda in 5 years |
|
59.49 | 107.17 | -44.49% | ||
| Growth impulse Net Income in 5 years |
|
58.14 | 123.16 | -52.79% | ||
| Growth impulse FCF in 5 years |
|
37.59 | 93.68 | -59.87% | ||
| Growth impulse EPS in 5 years |
|
959.27 | 229.02 | 318.86% |
IP Score
7.99/10
